Top Markets
Coin of the day
MDxHealth S.A. MDxHealth S.A.

MDxHealth S.A.

MDXH
株式のランク #21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
株価
$3.58
最終同期: 2023-12-15
時価総額
$101.57M
変化(1日)
3.79%
変化(1年)
0.00%
BE
取引 MDxHealth S.A. (MDXH)

カテゴリー

MDxHealth S.A.(MDXH)のP/S比率
2026 時点のP/S比率 TTM: 0
MDxHealth S.A. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
MDxHealth S.A. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率